The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

PURPOSE: High-risk patients with stage II colon cancer (CC) may benefit from adjuvant chemotherapy, but additional prognostic markers are needed for better stratification. We investigated the prognostic value of tumour stroma ratio (TSR) and tumour budding (TB). METHODS: A nationwide population-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksen, Ann Christina, Sørensen, Flemming B., Lindebjerg, Jan, Hager, Henrik, dePont Christensen, René, Kjær-Frifeldt, Sanne, Hansen, Torben F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060800/
https://www.ncbi.nlm.nih.gov/pubmed/29785462
http://dx.doi.org/10.1007/s00384-018-3076-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060800/
https://www.ncbi.nlm.nih.gov/pubmed/29785462
http://dx.doi.org/10.1007/s00384-018-3076-9

Ejemplares similares